Ugrás a tartalomra
Merck
Összes fotó(1)

Fontos dokumentumok

AB1129

Sigma-Aldrich

Anti-Rotavirus Antibody

Chemicon®, from goat

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez


About This Item

UNSPSC kód:
12352203
eCl@ss:
32160702
NACRES:
NA.41
klón:
polyclonal
application:
ELISA
IF
IHC
WB
faj reaktivitás:
human
technika/technikák:
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
citations:
8

biológiai forrás

goat

Minőségi szint

antitest forma

purified immunoglobulin

klón

polyclonal

faj reaktivitás

human

gyártó/kereskedő neve

Chemicon®

technika/technikák

ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable

kiszállítva

wet ice

Egyediség

Rotavirus (ICP′s and late structural virion antigens). Greater than 90% reactive with human rotaviruses. Non reactive with HEp-2 cells and WI-38 cells.

Immunogén

Bovine (Nebraska Calf Diarrhea Virus)

Alkalmazás

Indirect immunofluorescence: 1:250

ELISA

Immunoblotting; unboiled samples in 1mM DTT and 2% SDS only.

Immunohistochemistry

Final working dilutions must be determined by end user.
Research Category
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
This Anti-Rotavirus Antibody is validated for use in ELISA, IF, WB, IH for the detection of Rotavirus.

Fizikai forma

Format: Purified
Purified immunoglobulin. In PBS (0.01 M, pH 7.2) with 0.1% sodium azide

Tárolás és stabilitás

Maintain at -20°C in undiluted aliquots for up to 12 months. Avoid repeated freeze/thaw cycles.

Jogi információk

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Jogi nyilatkozat

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Tárolási osztály kódja

12 - Non Combustible Liquids

WGK

WGK 2

Lobbanási pont (F)

Not applicable

Lobbanási pont (C)

Not applicable


Analitikai tanúsítványok (COA)

Analitikai tanúsítványok (COA) keresése a termék sarzs-/tételszámának megadásával. A sarzs- és tételszámok a termék címkéjén találhatók, a „Lot” vagy „Batch” szavak után.

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Mai Kishimoto et al.
Journal of virology, 97(1), e0145522-e0145522 (2023-01-13)
Rotavirus A (RVA) causes diarrheal disease in humans and various animals. Recent studies have identified bat and rodent RVAs with evidence of zoonotic transmission and genome reassortment. However, the virological properties of bat and rodent RVAs with currently identified genotypes
Christina McCowan et al.
PloS one, 13(9), e0203853-e0203853 (2018-09-12)
Cases of vomiting and diarrhoea were reported in racing pigeons in Western Australia in May, 2016. Morbidity and mortality rates were high. Similar clinical disease was seen in Victoria in December and by early 2017 had been reported in all
Na Yin et al.
World journal of gastroenterology, 24(45), 5109-5119 (2018-12-21)
To establish a rotavirus (RV)-induced diarrhea model using RV SA11 in neonatal rhesus monkeys for the study of the pathogenic and immune mechanisms of RV infection and evaluation of candidate vaccines. Neonatal rhesus monkeys with an average age of 15-20
Wook-Jin Park et al.
Scientific reports, 11(1), 22037-22037 (2021-11-13)
Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen;
Na Yin et al.
Human vaccines & immunotherapeutics, 17(12), 5656-5665 (2022-02-27)
Live-attenuated rotavirus vaccine has shown low protection in underdeveloped or developing countries. However, the inactivated rotavirus vaccine may have the potential to overcome some of these challenges. In the present study, the immunogenicity and protective efficacy of a bivalent inactivated

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással